EQUITIES

Robust. Fundamental. Dynamic.

Our teams exercise independent thought with high conviction, resulting in portfolios that we believe are well positioned to address our clients' challenges – all within robust risk control frameworks.

vd-icon_Currency_CashUSD

$243.6bn
Equities Assets Under Management

vd-icon_People_3_Group v3

148
Equities Investment
Professionals

vd-icon_Bulleye_Target v3

19
Average Years’ Financial
Industry Experience

As at 30 June 2025

<span class="notranslate">no data</span>

$243.6bn
Equities Assets Under Management

148
Equities Investment
Professionals

19
Average Years’ Financial
Industry Experience

As at 30 June 2025

We measure success by a single factor: client outcomes. As a pure asset manager, our sole mission is to deliver consistent long-term risk-adjusted returns that exceed our benchmarks and peers, regardless of the prevailing investment landscape.

Featured strategies

Global Life Sciences

By understanding the science and business of health care, our experienced team seeks to invest in companies addressing unmet medical needs or improving efficiencies.

Biotechnology Innovation

A biotechnology strategy that seeks to leverage a disciplined approach to identify compelling opportunities across the biotech landscape in both public and private investments

Global Technology Leaders

A global approach to investing in technology companies from a highly experienced team

Insights

Are tech sector investors too bullish on AI’s promise?

The tech sector today has significantly evolved from the dotcom era.

Drug pricing reform and trade deals signal support for biopharma innovation

New developments around pharmaceutical tariffs and U.S. drug pricing reform suggest the hit to the biopharma industry may, over time, be less than feared.

Commutes crossing London Bridge in the morning with an image of the sun rising up behind Tower Bridge.

UK equities: Stronger sterling and stabilising flows signal shifting sentiment

Portfolio Manager Indriatti Van Hien believes that despite geopolitical tensions and fiscal uncertainties, stabilising capital flows and easing inflationary pressures offer a promising outlook for UK equities.